Cargando…

Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis

BACKGROUND: Stage-specific survival, according to the eighth edition of the American Joint Committee on Cancer (AJCC) pathological prognostic staging (PPS) on breast cancer (BC), between Chinese and White American women remains unclear. OBJECTIVE: This study aimed to assess stage-specific survival i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Zhou, Juan, Liu, Lei, Wu, San-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709668/
https://www.ncbi.nlm.nih.gov/pubmed/36378507
http://dx.doi.org/10.2196/40386
_version_ 1784841207699996672
author Wang, Jun
Zhou, Juan
Liu, Lei
Wu, San-Gang
author_facet Wang, Jun
Zhou, Juan
Liu, Lei
Wu, San-Gang
author_sort Wang, Jun
collection PubMed
description BACKGROUND: Stage-specific survival, according to the eighth edition of the American Joint Committee on Cancer (AJCC) pathological prognostic staging (PPS) on breast cancer (BC), between Chinese and White American women remains unclear. OBJECTIVE: This study aimed to assess stage-specific survival in BC between Chinese and White American women according to the eighth AJCC PPS. METHODS: We included Chinese and White American women with BC diagnosed between 2010 and 2018 from the Surveillance, Epidemiology, and End Results database. A chi-square test, the Kaplan–Meier method, a receiver operating characteristic (ROC) curve, and multivariate Cox proportional hazards models were used for data analysis. RESULTS: We included 376,818 individuals in this study: 369,522 White American and 7296 Chinese. Of them, 149,452 (39.7%) migrated from the seventh AJCC anatomic staging (AS) to the eighth AJCC PPS, 22,516 (6.0%) were upstaged, and 126,936 (33.7%) were downstaged. With a median follow-up duration of 44 months, the 5-year overall survival and cancer-specific survival (CSS) for the entire group were 87.4% and 95.9%, respectively. The seventh AJCC AS (P<.001) and the eighth AJCC PPS (P<.001) could significantly predict the survival outcomes of BC, and multivariate analysis revealed that both staging systems were significant prognostic indicators of CSS. The ROC curve revealed that the PPS had a better discriminating ability than the AS (area under the curve [AUC] 0.769 vs 0.753, P<.001). Similar trends were observed after stratification by the 2 ethnic groups. The eighth AJCC PPS had better discriminating ability than the seventh AJCC AS among both White American (AUC 0.769 vs 0.753, P<.001) and Chinese patients (AUC 0.790 vs 0.776, P<.001). In the seventh AJCC AS, Chinese women had better CSS in stage IA (P=.02), stage IIA (P=.005), and stage IIIB (P=.04) disease than White American women, but no significant CSS was observed in stage IB, IIB, IIIA, and IIIC disease between the 2 ethnic groups. Regarding the eighth AJCC PPS, Chinese women had better CSS in stage IA (P=.002) and IIIA (P=.046) disease than White American women, and CSS was similar in Chinese and White American women in other substages. CONCLUSIONS: The eighth AJCC PPS has a similar discriminative ability between White American and Chinese individuals with BC compared with the seventh AJCC AS. Therefore, the eighth AJCC PPS is also applicable to Chinese individuals with BC.
format Online
Article
Text
id pubmed-9709668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-97096682022-12-01 Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis Wang, Jun Zhou, Juan Liu, Lei Wu, San-Gang JMIR Public Health Surveill Original Paper BACKGROUND: Stage-specific survival, according to the eighth edition of the American Joint Committee on Cancer (AJCC) pathological prognostic staging (PPS) on breast cancer (BC), between Chinese and White American women remains unclear. OBJECTIVE: This study aimed to assess stage-specific survival in BC between Chinese and White American women according to the eighth AJCC PPS. METHODS: We included Chinese and White American women with BC diagnosed between 2010 and 2018 from the Surveillance, Epidemiology, and End Results database. A chi-square test, the Kaplan–Meier method, a receiver operating characteristic (ROC) curve, and multivariate Cox proportional hazards models were used for data analysis. RESULTS: We included 376,818 individuals in this study: 369,522 White American and 7296 Chinese. Of them, 149,452 (39.7%) migrated from the seventh AJCC anatomic staging (AS) to the eighth AJCC PPS, 22,516 (6.0%) were upstaged, and 126,936 (33.7%) were downstaged. With a median follow-up duration of 44 months, the 5-year overall survival and cancer-specific survival (CSS) for the entire group were 87.4% and 95.9%, respectively. The seventh AJCC AS (P<.001) and the eighth AJCC PPS (P<.001) could significantly predict the survival outcomes of BC, and multivariate analysis revealed that both staging systems were significant prognostic indicators of CSS. The ROC curve revealed that the PPS had a better discriminating ability than the AS (area under the curve [AUC] 0.769 vs 0.753, P<.001). Similar trends were observed after stratification by the 2 ethnic groups. The eighth AJCC PPS had better discriminating ability than the seventh AJCC AS among both White American (AUC 0.769 vs 0.753, P<.001) and Chinese patients (AUC 0.790 vs 0.776, P<.001). In the seventh AJCC AS, Chinese women had better CSS in stage IA (P=.02), stage IIA (P=.005), and stage IIIB (P=.04) disease than White American women, but no significant CSS was observed in stage IB, IIB, IIIA, and IIIC disease between the 2 ethnic groups. Regarding the eighth AJCC PPS, Chinese women had better CSS in stage IA (P=.002) and IIIA (P=.046) disease than White American women, and CSS was similar in Chinese and White American women in other substages. CONCLUSIONS: The eighth AJCC PPS has a similar discriminative ability between White American and Chinese individuals with BC compared with the seventh AJCC AS. Therefore, the eighth AJCC PPS is also applicable to Chinese individuals with BC. JMIR Publications 2022-11-15 /pmc/articles/PMC9709668/ /pubmed/36378507 http://dx.doi.org/10.2196/40386 Text en ©Jun Wang, Juan Zhou, Lei Liu, San-Gang Wu. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 15.11.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Wang, Jun
Zhou, Juan
Liu, Lei
Wu, San-Gang
Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title_full Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title_fullStr Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title_full_unstemmed Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title_short Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
title_sort stage-specific survival in breast cancer in chinese and white women: comparative data analysis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709668/
https://www.ncbi.nlm.nih.gov/pubmed/36378507
http://dx.doi.org/10.2196/40386
work_keys_str_mv AT wangjun stagespecificsurvivalinbreastcancerinchineseandwhitewomencomparativedataanalysis
AT zhoujuan stagespecificsurvivalinbreastcancerinchineseandwhitewomencomparativedataanalysis
AT liulei stagespecificsurvivalinbreastcancerinchineseandwhitewomencomparativedataanalysis
AT wusangang stagespecificsurvivalinbreastcancerinchineseandwhitewomencomparativedataanalysis